Physician profile
Matthew Strang
NPI 1942793195
$649.14
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.54 · 2021: $109 · 2022: $298 · 2023: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.46 | 2022-2023 | Ubrelvy, Vraylar |
| Novo Nordisk INC | $102.00 | 2021-2023 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $84.08 | 2021-2023 | Prolia, Evenity |
| Lilly USA, LLC | $68.29 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $48.86 | 2022-2023 | Belsomra, Steglatro |
| Janssen Pharmaceuticals, INC | $45.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.19 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.99 | 2023 | Breztri |
| Daiichi Sankyo INC. | $18.23 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.50 | 2023 | Lifevest |
| Becton, Dickinson and Company | $17.00 | 2023 | Bd Onclarity |
| Exact Sciences Corporation | $14.25 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Strang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.